Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · American Funds (Capital Group)

Hillman Value Fund (HCMAX)

Ticker HCMAX · · Holdings as of Jun 30, 2026

Expense ratio
0.95%$95/yr per $10k
5-yr return
+9.5%annualized
1-yr return
+10.1%as of Dec 2025
Net assets
$78.4Mall share classes
Holdings
38

Bottom line

Is HCMAX a good fund? The bottom line

HCMAX is an actively managed large value mutual fund from American Funds (Capital Group).

Its expense ratio is 0.95% — about $95 a year on every $10,000 invested, more expensive than 62% of large value funds we track.

It returned +10.1% over one year, +9.5% a year over five years, +11.5% a year over ten (as of Dec 31, 2025, per its prospectus).

With $78.4 million in net assets and 38 holdings, its largest position is N/a (3.5%) and the top 10 make up 30.9% of the portfolio.

Updated Nov 19, 2026

What HCMAX invests in

The Fund seeks to provide long-term total return from a combination of income and capital gains.

In seeking to achieve its objective, the Fund invests primarily in common stocks of U.S. companies that the Adviser believes have competitive advantages, as described below, and have temporarily fallen out of favor for reasons that are considered non-recurring or short-term; whose value is not currently well known; or whose value is not fully recognized by the public. In selecting investments for the Fund, the Adviser first looks at qualitative measures of a company. Qualitative measures of a company include: ? dominance in a particular industry or niche market; ? qualifications and ability of management team; ? strength of pricing and purchasing power; ? barriers to industry competition and limited substitutes; ? limited degree of rivalry amongst competitors; ? strength of brand or franchise with commensurate brand loyalty; ? strength of balance sheet and sources of liquidity; and ?…

From the fund's prospectus (filed Jan 28, 2026).

HCMAX performance

Fund calendar-year total returns, 2016–2025 2016: +16.2%; 2017: +16.4%; 2018: −2.7%; 2019: +35.6%; 2020: +5.6%; 2021: +22.8%; 2022: −10.9%; 2023: +24.4%; 2024: +4.9%; 2025: +10.1% +16% 2016 +16% 2017 −3% 2018 +36% 2019 +6% 2020 +23% 2021 −11% 2022 +24% 2023 +5% 2024 +10% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
HCMAX+10.1%+9.5%+11.5%
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full HCMAX performance history →

What HCMAX costs

On a $10,000 investment, HCMAX's 0.95% expense ratio costs about $95 a year. The prospectus estimates $1,251 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full HCMAX fee table →

HCMAX top 10 holdings

#Holding% of fund
1N/a3.45%
2West Pharmaceutical Services Inc3.25%
3Veeva Systems Inc3.17%
4Cvs Health Corp3.10%
5Baxter International Inc3.08%
6United Parcel Service Inc3.06%
7Warner Bros Discovery Inc2.98%
8Dupont De Nemours Inc2.96%
9Taiwan Semiconductor Manufacturing Co Ltd2.92%
10Kraft Heinz Co/the2.87%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 30.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to HCMAX

More funds like HCMAX →

HCMAX FAQ

What is the expense ratio of HCMAX?
HCMAX's expense ratio is 0.95%, which works out to about $95 a year for every $10,000 invested. The prospectus estimates total costs of $1,251 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is HCMAX a good investment?
It depends on your goals, but the data points to: a typical fund for its category. This is general information, not personalized advice.
What does HCMAX hold?
HCMAX's largest holdings are N/a (3.5%), West Pharmaceutical Services Inc (3.3%), Veeva Systems Inc (3.2%), Cvs Health Corp (3.1%), Baxter International Inc (3.1%). It holds 38 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is HCMAX's 5-year return?
HCMAX returned +9.5% a year over the five years ending Dec 31, 2025, and +11.5% a year over ten years. Past performance does not guarantee future results.
Who manages HCMAX?
HCMAX is offered by American Funds (Capital Group) through ALPS Series Trust.